FDA PMA
FDA Class 3
30-Day Notice Accepted
🇺🇸 United States
Pump, Infusion, Implanted, Programmable
PMA: P860004
·
Supplement: S411
·
Decision Jun 7, 2023
Classifications
1
FEI Numbers
18
Registration Numbers
18
Basic Information
- Device Name
- Pump, Infusion, Implanted, Programmable
- Trade Name
- SynchroMed® Infusion System, Ascenda® Intrathecal Catheters
- PMA Number
- P860004
- Supplement Number
- S411
- Device Class
- FDA Class 3
- Product Code
- LKK
- Generic Name
- Pump, infusion, implanted, programmable
- Medical Specialty
- Unknown
- Advisory Committee
- General Hospital
- Decision
- 30-Day Notice Accepted
- Decision Code
- OK30
- Decision Date
- June 7, 2023
- Date Received
- May 11, 2023
- Supplement Type
- 30-Day Notice
- Supplement Reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Expedited Review
- N
Advisory Committee Statement
Supplier changes to a) use a new surfactant in the raw material manufacturing process; and b) to increase supplier production capacity in the filter manufacturing process for the SynchroMed Infusion System.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| LKK | Pump, Infusion, Implanted, Programmable | FDA class 3 | Unknown |